Your session is about to expire
← Back to Search
Vitamin D3 for Crohn's Disease (ViDiPeC-2 Trial)
ViDiPeC-2 Trial Summary
This trial is testing whether adding vitamin D to the usual treatment for Crohn's disease can improve symptoms and quality of life.
ViDiPeC-2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowViDiPeC-2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ViDiPeC-2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My Crohn's disease is mild with no current symptoms.I have been on a steady dose of Thiopurines, Methotrexate, or TNF-α inhibitors for at least 4 weeks.I have a permanent colostomy or ileostomy due to surgery.I have been on a steady dose of Thiopurines, Methotrexate, or TNF-α inhibitors for over 4 weeks.My Crohn's disease is mild with no current symptoms like abdominal pain or blood in stool.I am between 4 and 17 years old.I am between 4 and 17 years old.
- Group 1: Control Arm:
- Group 2: Experimental Arm:
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what conditions is vitamin D3 commonly prescribed?
"Vitamin D3 is not only used to manage calcium intake, but can also help with fractures, spine fractures, and post menopausal women."
How many subjects are being recruited for this research?
"A total of 316 individuals that meet the pre-determined inclusion criteria are required for this clinical trial. These patients can be recruited from multiple hospitals, including Stollery Children's Hospital in Edmonton, Alberta and Montreal Children's Hospital in London, Ontario."
Will this research opportunity be available to middle-aged patients?
"Based on the inclusion criteria, it appears that this clinical trial is for patients aged 4-18. There are 81 studies for patients under 18 and 222 for patients over 65."
What is the precedent for using vitamin D3 in medical research?
"There are 37 clinical trials studying vitamin D3, 15 of which are in Phase 3. Although many of these trials are based in Boston, Massachusetts, there are 171 locations across the United States running these trials."
Are there any potential dangers to patients when they take vitamin D3?
"There is existing clinical data supporting the safety of vitamin D3, thus it received a score of 3."
Are there any participating locations in North America for this research?
"This study is currently underway at Stollery Children's Hospital in Edmonton, Alberta; Montreal Children's Hospital in London, Ontario; and London Health Sciences Centre in Vancouver, British Columbia. Seven other locations are also participating."
Share this study with friends
Copy Link
Messenger